NOTICE OF INVESTIGATION
Section 196G of the
Veterans' Entitlements Act 1986
The Repatriation Medical Authority (the Authority) gives notice under section 196G of the Veterans' Entitlements Act 1986 (the VEA) that, pursuant to subsection 196B(7A) of the VEA, it intends to carry out an investigation in respect of exposure to DDT as a factor in malignant neoplasm of the pancreas.
This investigation will be carried out in the context of Statements of Principles Instrument Nos. 73 & 74 of 2013 concerning malignant neoplasm of the pancreas.
The Authority invites the following persons and organisations to make written submissions to the Authority in respect of the investigation:
a person eligible to make a claim for pension under Part II or Part IV of the VEA;
a person eligible to make a claim for compensation under section 319 of the Military Rehabilitation and Compensation Act 2004 (the MRCA);
an organisation representing veterans, Australian mariners, members of the Forces, members of the Peacekeeping Forces, members within the meaning of the MRCA, or their dependants;
the Repatriation Commission or the Military Rehabilitation and Compensation Commission; and
a person having expertise in a field relevant to the investigation.
The Authority will hold its first meeting for the purposes of this investigation on 10 April 2018.
Persons and organisations wishing to make a submission can use the RMA website http://www.rma.gov.au/investigations/ to electronically lodge the submission and supporting information. Alternatively, submissions can be sent by email to info@rma.gov.au or posted to the address below. The RMA Submission Guidelines are available online for guidance. The RMA Secretariat may be contacted at the address, telephone number or email address below for further assistance.
All submissions must be in writing and received by the Authority no later than 19 March 2018.
The Common Seal of the ) Repatriation Medical Authority ) was affixed at the direction of: ) | |
| PROFESSOR NICHOLAS SAUNDERS AO CHAIRPERSON 22 / 12 / 2017 |
Overview
The Repatriation Medical Authority, pursuant to section 196G of the Veterans' Entitlements Act 1986 (VEA), has issued a Notice of Investigation concerning the potential link between exposure to DDT and malignant neoplasm of the pancreas. Enacted by the Australian Parliament, the VEA was introduced to address the need for comprehensive and fair entitlements for veterans, ensuring that those who have served the nation are appropriately compensated for any health issues arising from their service. This investigation is being conducted in the context of Statements of Principles Instrument Nos. 73 and 74 of 2013, which pertain to malignant neoplasm of the pancreas. The Authority is inviting submissions from eligible claimants, representative organisations, and experts to provide input into this investigation, with the aim of thoroughly examining the evidence and its implications for affected veterans. Submissions are to be made by 19 March 2018, with the first meeting of the investigation scheduled for 10 April 2018.
Scope and Application
Section 196G of the Veterans' Entitlements Act 1986 (VEA) pertains to an investigation by the Repatriation Medical Authority (the Authority) into the potential link between exposure to DDT and the development of malignant neoplasm of the pancreas. This investigation is specifically related to the Statements of Principles Instrument Nos. 73 & 74 of 2013. The Authority is inviting submissions from various eligible groups and entities, including individuals who may claim pension or compensation under the VEA or the Military Rehabilitation and Compensation Act 2004, organisations representing veterans or their dependants, relevant commissions, and experts with pertinent field knowledge. The scope of the investigation is confined to Commonwealth jurisdiction, with the Authority accepting submissions from interested parties until 19 March 2018. Submissions can be lodged electronically via the RMA website, by email, or by post, adhering to the guidelines provided by the RMA Secretariat. This investigation is part of the ongoing efforts to assess and address health issues potentially linked to military service, ensuring that affected veterans receive appropriate recognition and support.
Key Provisions
The notice of investigation (section 196G of the Veterans' Entitlements Act 1986) issued by the Repatriation Medical Authority (the Authority) outlines its intention to investigate the potential link between exposure to DDT and the occurrence of malignant neoplasm of the pancreas. This investigation is conducted under the auspices of Statements of Principles Instrument Nos. 73 & 74 of 2013. Specifically, the Authority seeks to understand whether DDT exposure may act as a contributing factor to the development of pancreatic cancer among veterans and other eligible groups.
In line with the requirements of the Act, the Authority is inviting specific stakeholders to submit written submissions regarding the investigation. These stakeholders include individuals eligible to claim pensions under Part II or Part IV of the VEA, those eligible for compensation under section 319 of the Military Rehabilitation and Compensation Act 2004, organisations representing various groups such as veterans and their dependants, and entities like the Repatriation Commission or the Military Rehabilitation and Compensation Commission. Additionally, individuals with expertise relevant to the investigation are also encouraged to contribute. The Authority has provided multiple avenues for these submissions, including electronic submission via the RMA website, email, or postal mail. Submissions must be in written form and received by 19 March 2018 to be considered.
The obligations imposed by this Act on the relevant parties include the timely submission of written statements and supporting information by the specified groups. These submissions are intended to provide the Authority with comprehensive insights and data necessary for the investigation. Failure to comply with the submission deadline or the format requirements may result in the exclusion of the submission from the investigation process.
There are no explicit offences, penalties, or civil/criminal consequences outlined in the notice for failing to submit the required information. However, the Authority's ability to conduct a thorough and effective investigation may be compromised if submissions are not received on time or in the prescribed format. Such deficiencies could potentially impact the outcomes and recommendations of the investigation, affecting the rights and entitlements of those involved.